Regulatory fluctuations, corporate challenges, cross-category intersections, adult-use dominance, the ongoing rise of HDIC products and tailored product offerings are resulting in both challenges and opportunities for the cannabis industry.
The Top Five Trends in Cannabis Global report is designed specifically for current and potential stakeholders in the emerging legal cannabis market. It seeks to provide an in-depth overview of the size and scope of the global cannabis environment, examining the historic and future market trends. Delving into the forces shaping the emerging legal industry including regulatory momentum, dynamics of current illicit consumption, changing consumer behaviour and corporate activity, the report identifies opportunities and challenges across medical, adult-use cannabis and CBD. Forecasts in the reports are available to 2027.
Key findings
Regulatory ebbs and flows
- Cannabis regulatory developments are often hard to predict. This is likely to continue to be the case in the forecast period, especially as geopolitical and socioeconomic conflicts and challenges intensify. In this context, and considering the complexities that characterise the cannabis industry, governments are unlikely to see cannabis legalisation as a top priority.
Adult-use legacy and cross-category interpositions
- Although the opening of the cannabis industry has been occurring across the medical, CBD & other non-intoxicating cannabinoids, and adult-use categories, the latter is usually the most influential category in terms of revenue generation and impact on general cannabis-related legislative developments.
Continuous rise of intoxicating hemp-derived products
- Hemp-derived intoxicating products are still proliferating, and the consequences are manifold. While it has been enhancing the competition with the legal adult-use category and increasing the chances of cannabis scrutiny from governmental bodies, health authorities and consumers, it has also been opening revenue opportunities in markets in which HDIC products are regulated.
Increasingly tailored product innovation
- Cannabis product innovation has been touching on a range of features and functionalities, making them more appealing to a wider breadth of consumers and consequently increasing the “democratisation” and “normalisation” of cannabis.
Corporate challenges in uncertain periods
- The last couple of years have been challenging for some cannabis companies, most notably in mature markets such as the US and Canada. Unclear legislative frameworks, high tax burdens, oversupply issues, price decreases, low profitability and an uncertain macroeconomic scenario are among the difficulties that cannabis players have had to confront.
Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Cannabis market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.